Syndax Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.About SNDX
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES.
SNDX Key Statistics
Stock Snapshot
The current Syndax Pharmaceuticals(SNDX) stock price is $15.06, with a market capitalization of 1.31B. The stock trades at a price-to-earnings (P/E) ratio of -4.25.
As of 2025-11-05, Syndax Pharmaceuticals(SNDX) stock has fluctuated between $14.27 and $15.34. The current price stands at $15.06, placing the stock +5.6% above today's low and -1.8% off the high.
The Syndax Pharmaceuticals(SNDX)'s current trading volume is 3.36M, compared to an average daily volume of 4.81M.
During the past year, Syndax Pharmaceuticals(SNDX) stock moved between $8.58 at its lowest and $22.50 at its peak.
During the past year, Syndax Pharmaceuticals(SNDX) stock moved between $8.58 at its lowest and $22.50 at its peak.
SNDX News
Syndax Pharmaceuticals Inc. ((SNDX)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage...
Syndax Pharmaceuticals Inc. ( (SNDX) ) has released its Q3 earnings. Here is a breakdown of the information Syndax Pharmaceuticals Inc. presented to its investo...
Earnings Call Insights Syndax targets $10B market as Revuforj gains NPM1 approval and Q3 revenue rises 21% Nov. 03, 2025 9:07 PM ET Syndax Pharmaceuticals, Inc....
